Regulation of serotonin transport in human platelets by tyrosine kinase syk

Cellular Physiology and Biochemistry

Volumn 27, Issue 2, 2011, Pages 139-148

  Pavanetto, Martina ^a   Zarpellon, Alessandro ^a   Borgo, Christian ^a   Donella Deana, Arianna ^a   Deana, Renzo ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Human platelets; Serotonin transport; Syk tyrosine kinase

Indexed keywords

IMIPRAMINE; MEMBRANE PROTEIN; MONENSIN; PICEATANNOL; PROTEIN KINASE SYK; PROTEIN SERT; PROTEIN TYROSINE KINASE; SEROTONIN; UNCLASSIFIED DRUG;

ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SEROTONIN RELEASE; SEROTONIN UPTAKE; THROMBOCYTE;

EID: 79951609888     PISSN: 10158987     EISSN: None     Source Type: Journal    
DOI: 10.1159/000325216     Document Type: Article

References (60)

1. Jacobs BL, Amzitia EC: Structure and function of the brain serotonin system. Physiol Rev 1992;72:165-229.
2. Hensler JG: Serotonin, in Segel G, Albers RW, Brady S, Price D (eds): Basic Neurochemistry. Molecular, cellular and medical aspects, seventh ed., Elsevier Academic Press, Burlington, MA, 2006, pp 227-248.
3. Gershon MD, Tack J: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterol 2007;132:397-414. (Pubitemid 46127672)
4. Leonard BE: Antidepressant effect on neurotransmitters, in Kasper S, den Boer JA, Ad Sitsen J (eds): Handbook of depression and anxiety, second ed., Taylor & Francis Publ., London, 2007, pp 560-582.
5. Savitz J, Lucki I, Drevets WC: 5-HT(1A) receptor function in major depressive disorders. Progr Neurobiol 2009;88:17-31.
6. Da Prada M, Cesura AM, Launay JM, Richards JG: Platelets as a model for neurones?. Experientia 1988;44:115-126. (Pubitemid 18074244)
7. Lesch KP, Wolozin BL, Murphy DL, Reiderer P: Primary structure of the human platelet serotonin uptake site: identity with the brain serotonin transporter. J Neurochem 1993;160:2319-2322. (Pubitemid 23148809)
8. Rausch JL, Johnson ME, Li J, Hutchenson J, Carr BM, Corley KM, Gowans AB, Smith J: Serotonin transport kinetics correlated between human platelets and brain synaptosomes. Psycopharmacol 2005:180:391-398. (Pubitemid 40905028)
9. Rudnick G, Humphreys CJ: Platelet serotonin transporter. Methods Enzymol 1992;215:213-224.
10. Aughan RA, Huff RA, Uhl GR, Kuhar MJ: Protein kinase C-mediated phosphorylation and functional regulation of dopamine transporters in striatal synaptosomes. J Biol Chem 1997:272:15541-15546. (Pubitemid 27255584)
11. Ramamoorthy S, Giovanetti E, Qian Y, Blakely RD: Phosphorylation and regulation of antidepressant-sensitive serotonin transporters. J Biol Chem 1998:273:2458-2466. (Pubitemid 28069306)
12. Jayanthi LD, Samuvel DJ, Blakely RD, Ramamoorthy S: Evidence for biphasic effect of protein kinase C on serotonin transporter function, endocytosis, and phosphorylation. Molec Pharmacol 2005;67:2077-2087. (Pubitemid 41007790)
13. Ramamoorthy S, Samuvel DJ, Buck ER, Rudnick G, Jayanthi LD: Phosphorylation of threonine residue 276 is required for acute regulation of serotonin transporter by cyclic GMP. J Biol Chem 2007;282:11639-11647. (Pubitemid 47100698)
14. Pacholczyk T, Blakely RD, Amara SG: Expression cloning of a cocaine- and antidepressant-sensitive human noradrenaline transporter. Nature 1991;350:350-354. (Pubitemid 21912229)
15. Chen JG, Liu-Chen S, Rudnick G: Determination of external loop topology in the serotonin transporter by site-directed chemical labeling. J Biol Chem 1998;273:12675-12681. (Pubitemid 28240647)
16. Androutsellis-Theotokis A, Rudnick G: Accessibility and conformational coupling in serotonin transporter predicted internal domains. J Neurosci 2002;22:8370-8378. (Pubitemid 35387577)
17. - -dependent serotonin transporter expressed using recombinant baculovirus in insect cells. J Biol Chem 1994;269:26303-26310.
18. Rudnick G, Wall SC: p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry 1992;31:6710-6718.
19. Hilber B, Scholze P, Dorostkar MM, Sandtner W, Holy M, Boehm S, Singer EA, Sitte HH: Serotonin-transporter mediated efflux: a pharmacological analysis of amphetamins and non-amphetamines. Neuropharmacol 2005;49:811-819. (Pubitemid 41483887)
20. + gradients by ionophores (nigericin, monensin) on serotonin transport in human blood platelets. Biochim Biophys Acta 1977;468:284-295. (Pubitemid 8180759)
21. Levi G, Raiteri M: Carrier-mediated release of neurotransmitters. Trends Neurosci 1993;16:415-419. (Pubitemid 23283403)
22. Sitte HH, Hiptmair B, Zwach J, Pifl C, Singer EA, Scholze P: Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: inconsistencies with the hypothesis of facilitated exchange diffusion. Mol Pharmacol 2001;59:1129-1137. (Pubitemid 32381593)
23. + concentration increase in human platelets. Cell Physiol Biochem 2004;14:377-386.
24. Sada K, Takano T, Yanagi S, Yamamura H: Structure and function of Syk protein-tyrosine kinase. J Biochem 2001;130:177-186. (Pubitemid 32785863)
25. Coopman PJ, Mueller SC: The Syk tyrosine kinase a new negative regulator in tumour growth and progression. Cancer Lett 2006;241:159-173. (Pubitemid 44163045)
26. Ghosh D, Tsokos GC: Spleen tyrosine kinase: an Src family of non-receptor kinase has multiple functions and represents a valuable therapeutic target in the treatment of autoimmune and inflammatory diseases. Autoimmunity 2010;43:48-55.
27. 2+ mobilization in platelets. J Biol Chem 1993;268:2277-2279. (Pubitemid 23057835)
28. Poole A, Gibbins JM, Turner M, van Vugt MJ, van de Winkel JG, Saito T, TybulewiczVL, Watson SP: The Fc receptor gamma-chain and the tyrosine kinase Syk are essential for activation of mouse platelets by collagen. EMBO J 1997;16:2333-2341. (Pubitemid 27258634)
29. Gao J, Zoller KE, Ginsberg MH, Brugge JS, Shattil SJ: Regulation of the pp72syk protein tyrosine kinase by platelet integrin αIIbβ3. EMBO J 1997;16:6414-6425. (Pubitemid 27483268)
30. Law DA, Nannizzi-Alaimo L, Ministri K, Hughes PE, Forsyth J, Turner M, Shattil SJ, Ginsberg MH, Tybulewicz VL, Phillips DR: Genetic and pharmacological analyses of Syk function in alphaIIbbeta3 signaling in platelets. Blood 1999;93:2645-2652. (Pubitemid 29181197)
31. Jones ML, Harper MT, Aitken EW, Williams CM, Poole AW: RGD-ligand mimetic antagonists of integrin alphaIIbbeta3 paradoxically enhance GPVI-induced human platelet activation. J Thromb Haemost 2010;8:567-576.
32. Speich HE, Grgurevich S, Kueter TJ, Earhart AD, Slack SM, Jennings L: Platelets undergo phosphorylation of Syk at Y525/526 and Y352 in response to pathophysiological shear stress. Am J Physiol Cell Physiol 2008;295:C1045-C1054.
33. Turetta L, Bazzan E, Bertagno K, Musacchio E, Deana R: Role of Ca(2+) and protein kinase C in the serotonin (5-HT) transport in human platelets. Cell Calcium 2002;31:235-244. (Pubitemid 34778059)
34. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantitites of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
35. Zarpellon A, Donella-Deana A, Folda A, Turetta L, Pavanetto M, Deana R: Serotonin (5-HT) transport in human platelets is modulated by Src-catalysed Tyr-phosphorylation of the plasma membrane transporter SERT. Cell Physiol Biochem 2008;21:87-94.
36. Bain J, McLauchlan H, Elliott M, Cohen P: The specificities of protein kinase inhibitors: an update. Biochem J 2003;371:199-204. (Pubitemid 36458094)
37. Bhavaraju K, Kim S, Daniel JL, Kunapuli SP: Evaluation of [3-(1-methyl-1H-indol-3-yl-methylene)-2-oxo-2,3-dihydro-1H-indole-5-sulfonamide] (OXSI-2), as a Syk-selective inhibitor in platelets. Eur J Pharmacol 2008;580:285-290.
38. Affolter H, Pletscher A: Storage of biogenic amines in intact blood platelets of man. Dependence on proton gradient. Molec Pharmacol 1988;22:94-98.
39. Rudnick G: Mechanisms of biogenic amines, in Reith MEA (ed): Neurotransmitter Transporters: Structure, Function, and Regulation, second ed., Humana Press, Totowa NJ, 2002, pp 25-52.
40. Brenner B, Harney JT, Ahmed BA, Jeffus BC, Unal R, Mehta JL, Kilic F: Plasma serotonin level and the platelet serotonin transporter. J Neurochem 2007;102:206-215. (Pubitemid 46906271)
41. Dmitriev AD, Factor MI, Segal OL, Pavlova EV, Massino YS, Smirnova MB, Yakovleva DA, Dmitriev DA, Kizim EA, Kolyaskina GI, Brusov OS: Western blot analysis of human and rat serotonin transporter in platelets and brain using site-specific antibodies: evidence that transporter undergoes endoproteolytic cleavage. Clin Chim Acta 2005;356:76-94. (Pubitemid 40779888)
42. Anderson NG: Co-immuno-precipitation: identification of interacting proteins, in: Clegg RA, (ed): Methods in Molecular Biology. Humana Press, Totowa NJ, 1998, vol. 88, pp 35-45.
43. Negro A, Brunati AM, Donella-Deana A, Massimino ML, Pinna LA: Multiple phosphorylation of alpha-synuclein by protein tyrosine kinase Syk prevents eosin-induced aggregation. FASEB J 2002;16:210-212.
44. 14 C-serotonin uptake, and the surface area of blood platelets. Prog Neuropsychopharmacol Biol Psychiatry 1990;14:289-296. (Pubitemid 20191893)
45. Rao ML, Frahnert C, Zagorski O: Initial serotonin transport into viable platelets and imipramine binding to platelet membranes. J Neural Transm 2002;109:547-556. (Pubitemid 34810755)
46. Anderson GM, Horne WC: Activators of protein kinase C decrease serotonin transport in human platelets. Biochim Biophys Acta 1992;1137:331-337.
47. Sakai N, Sasaki K, Nakashita M, Honda S, Ikegaki N, Saito N: Modulation of serotonin transporter activity by a protein kinase C activator and an inhibitor of type 1 and 2A serine/ threonine phosphatases. J Neurochem 1997;68:2618-2624. (Pubitemid 27218187)
48. Carneiro AM, Blakely RD: Serotonin, protein kinase C and HIC-5 associated redistribution of the platelet serotonin transporter. J Biol Chem 2006;281:24769-24780. (Pubitemid 44274251)
49. Samuvel DJ, Jayanthi LD, Bhat NR, Ramamoorthy SA: A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 2005;25:29-41. (Pubitemid 40110763)
50. Zhu CB, Carneiro AM, Dostmann WR, Hewlett WA, Blakely RD: p38 MAPK activation elevates serotonin transport activity via a trafficking-independent, protein phosphatase 2A-dependent process. J Biol Chem 2005;280:15649-15658. (Pubitemid 40616683)
51. Wersinger C, Rusnak M, Sidhu A: Modulation of the trafficking of the human serotonin transporter by human alpha-synuclein. Eur J Neurosci 2006;24:55-64. (Pubitemid 44050666)
52. Wolfel R, Graefe K-H: Evidence for various tryptamines and related compounds acting as substrates of the platelet 5-hydroxytryptamine transporter. Arch Pharmacol 1992;345:129-136.
53. Talvenheimo J, Fishkes H, Nelson PJ, Rudnick G: The serotonin transporter-imipramine 'receptor': Different sodium requirements for imipramine binding and serotonin translocation. J Biol Chem 1983;258:6115-6119. (Pubitemid 13106787)
54. Fog JU, Khoshbouei H, Holy M, Owens WA, Vaegter CB, Sen N, Nikandrova Y, Bowton E, McMahon DG, Colbran RJ, Daws LC, Sitte HH, Javitch JA, Galli A, Gether U: Calmodulin kinase II interacts with the dopamine transporter C terminus to regulate amphetamine-induced reverse transport. Neuron 2006;51:417-429. (Pubitemid 44219035)
55. Sucic S, Dallinger S, Zdrazil B, Weissensteiner R, Jorgensen TN, Holy M, Kudlacek O, Seidel S, Hwan Cha JH, Gether U, Newman AH, Ecker GF, Freissmuth M, Sitte HH: The amino terminus of monoamine transporters is a lever required for the action of amphetamines. J Biol Chem 2010;285:10924-10938.
56. Helmeste DM, Tang SW: Tyrosine kinase inhibitors regulate serotonin uptake in platelets. Eur J Pharmacol 1995;280:R5-R7.
57. - -coupled neurotransmitter transporter - why amphetamine take two to tango. J Neurochem 2010;112:340-355.
58. Willeit M, Sitte HH, Thierry N, Michalek K, Praschak-Rieder N, Zill P, Winkler D, Brannath W, Fischer MB, Bondy B, Kasper S, Singer EA: Enhanced serotonin transporter function during depression in seasonal affective disorders. Neuropsychopharmacol 2008;33:1503-1513. (Pubitemid 351684718)
59. Qian Y, Melikian HE, Rye DB, Levey AI, Blakely RD: Identification and characterization of antidepressant-sensitive serotonin transporter proteins using site-specific antibodies. J Neurosci 1995;15:1261-1274.
60. Butler SG, Meegan MJ: Recent developments in the design of anti-depressive therapies: targeting the serotonin transporter. Curr Med Chem 2008;15:1737-1761.